Kreon (Pancreas Powder)

Pancreas Powder supplies a blend of lipase, protease, and amylase that act in the small intestine to hydrolyze dietary fats, proteins, and carbohydrates. By providing these exogenous enzymes, it compensates for the deficient endogenous pancreatic output, facilitating normal nutrient breakdown and absorption.

The dose of Kreon is individualized and determined by the prescribing healthcare professional based on the patient’s clinical condition, dietary fat content, and response to therapy. No fixed regimen is provided here; the prescriber will set the appropriate dosage and administration schedule.

Safety data for Kreon in pregnancy and lactation are limited. It should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant. Consultation with a qualified healthcare provider is essential before starting therapy in these situations.

To order Kreon, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams worldwide, and will request verification of trade or institutional credentials. The team then replies with pricing, availability, shipping details and any required import documentation.

Kreon contains a standardized mixture of lipase, protease, and amylase similar to other porcine‑derived pancreatic enzyme preparations such as Creon or Pancrelipase. Differences may lie in enzyme potency, capsule size, and dosing flexibility. Clinical choice often depends on physician preference, patient tolerance, and specific dosing requirements.

Kreon should be stored at room temperature below 25 °C, in its original container, protected from moisture and direct sunlight. Do not refrigerate or freeze the product. Ensure the packaging remains sealed until use to maintain enzyme stability.

Kreon is taken orally, usually with each main meal and snack that contains fat. The capsules can be swallowed whole or opened and the powder sprinkled onto soft food, provided the mixture is consumed immediately. Follow the prescriber’s instructions regarding timing relative to meals.

Serious risks include allergic reactions that may progress to anaphylaxis, severe abdominal pain indicating possible pancreatitis exacerbation, and rare cases of intestinal obstruction. Patients should seek immediate medical attention if they experience difficulty breathing, swelling, intense abdominal pain, or persistent vomiting.

Kreon should not be used by individuals with a known hypersensitivity to porcine‑derived pancreatic enzymes or any of the product’s excipients. Caution is also advised for patients with severe gastrointestinal disorders where enzyme therapy may be contraindicated. A healthcare professional should evaluate suitability before initiating treatment.